A case report of a new pulmonary embolism occurring in a patient receiving continuous infusion of recombinant activated protein C

BACKGROUND: There are no guidelines governing the concomitant use of recombinant human activated protein C (rhAPC) and deep venous thrombosis/pulmonary embolism (DVT/PE) prophylaxis in critically ill patients. It is unknown if rhAPC provides any protection against DVT/PE in this population of patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Benedetto, Bernard J, Houston, Michael A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557485/
https://www.ncbi.nlm.nih.gov/pubmed/16899129
http://dx.doi.org/10.1186/1749-7922-1-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557485/
https://www.ncbi.nlm.nih.gov/pubmed/16899129
http://dx.doi.org/10.1186/1749-7922-1-23

Ejemplares similares